Effects of Dry Needling on Vertical Jump Performance
Launched by SIERRA VARONA SL · Dec 14, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a treatment called dry needling might improve vertical jump performance in female volleyball players. Dry needling involves inserting very thin needles into specific muscle points to relieve tension and improve muscle function. The researchers want to see if this treatment can help players who have tightness in their calf muscles, which can affect their jumping ability.
To participate in the study, women aged 18 to 30 who play volleyball and have not had any lower limb injuries in the last six months can apply. They should also have tight spots in their calf muscles, known as latent myofascial trigger points, and be comfortable performing a specific jumping test called the counter-movement jump. Participants will be randomly assigned to either receive the dry needling treatment or be in a control group, without knowing which group they are in. This trial is still in the planning stage and hasn’t started recruiting participants yet.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • No lower limb injuries in the last 6 months
- • Presence of latent MTPs in gastrocnemius
- • Be familiar with performing CMJ tests
- Exclusion Criteria:
- • Needle phobia
- • Presence of active MTPs in the lower limb
- • Any pathology that prevented the use of dry needling
- • Any pathology that prevented the performance of CMJ test.
About Sierra Varona Sl
Sierra Varona SL is a dynamic clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing cutting-edge therapies across various therapeutic areas, the organization collaborates closely with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of quality and ethical compliance in clinical studies. Sierra Varona SL is committed to enhancing patient outcomes through rigorous scientific methodologies and a patient-centered approach, positioning itself as a trusted partner in the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported